Trials / Recruiting
RecruitingNCT06577857
Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study
Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure: Long-Term Follow-Up Extension Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 53 (estimated)
- Sponsor
- Sanoculis Ltd · Industry
- Sex
- All
- Age
- 40 Years – 85 Years
- Healthy volunteers
- —
Summary
A long-term (24 and 30 months) follow-up extension, prospective, non-interventional, open label study for data collection from subjects who underwent prior MIMS® inferonasal surgery, in continuation of the previous clinical investigation with the MIMS® Device (MMS-EEU-5).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Inferonasal Minimally Invasive Micro Sclerostomy | The Inferonasal MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the inferonasal quadrant of the eye. |
Timeline
- Start date
- 2022-11-04
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
- First posted
- 2024-08-29
- Last updated
- 2024-09-26
Locations
1 site across 1 country: Armenia
Source: ClinicalTrials.gov record NCT06577857. Inclusion in this directory is not an endorsement.